TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32574117

Group type: EXPERIMENTAL
Intervention: Bortezomib plus dexamethasone (BD)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Bortezomib plus dexamethasone plus cyclophosphamide (C‐BD)
Number of subjects: 92
Study: 35133671

Group type: EXPERIMENTAL
Intervention: Losartan 100 mg orally once daily for 24 weeks
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Losartan 100 mg
Number of subjects: 110
Study: 33600460

Group type: EXPERIMENTAL
Intervention: Maternal height
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Improved drinking water source
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Elevated AGP
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Sex (female vs. male)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Serum RBP
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: Protein intake
Number of subjects: 230
Study: 35058272

Group type: EXPERIMENTAL
Intervention: Active-fluidics system
Number of subjects: 110

Group type: COMPARATOR
Intervention: Gravity-fluidics system
Number of subjects: 110
Study: 32629112

Group type: EXPERIMENTAL
Intervention: Oral (PO) antibiotic therapy
Number of subjects: 323

Group type: COMPARATOR
Intervention: Intravenous (IV) antibiotic therapy
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Duration of antibiotic therapy
Number of subjects: 323
Study: 35668441

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Moxibustion
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Acupuncture and Moxibustion
Number of subjects: 92
Study: 33566838

Group type: EXPERIMENTAL
Intervention: Doppelganger-based training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Avatar of the same gender
Number of subjects: 0
Study: 34396468

Group type: EXPERIMENTAL
Intervention: Cereboost® (American ginseng extract)
Number of subjects: 61
Study: 33640068

Group type: EXPERIMENTAL
Intervention: Targeted IRS
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard IRS
Number of subjects: 0
Study: 32611831

Group type: EXPERIMENTAL
Intervention: 8-lncRNA-based classifier for overall survival (OS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 14-lncRNA-based classifier for recurrence
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Molecular-clinicopathological nomograms based on classifiers
Number of subjects: 0
Study: 33421042

Group type: EXPERIMENTAL
Intervention: Clam Extract (CE) capsules, 3 times a day for 2 weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group received empty capsules identical in appearance to CE capsules
Number of subjects: 52
Study: 34293124

Group type: EXPERIMENTAL
Intervention: DHA (4 g/day for 4 weeks in the form of DHA-rich fish oil)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ALA (4 g/day for 4 weeks in the form of ALA-rich flaxseed oil)
Number of subjects: 0
Study: 32096243

Group type: EXPERIMENTAL
Intervention: Free gingival grafts (FGGs)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No-surgery (control)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Delayed FGG group (8 implants from control group)
Number of subjects: 18
Study: 33546912

Group type: EXPERIMENTAL
Intervention: High intrinsic motivation GPs
Number of subjects: 846

Group type: EXPERIMENTAL
Intervention: Most intrinsically motivated GPs exposed to external regulation (accreditation)
Number of subjects: 846
Study: 32334620

Group type: EXPERIMENTAL
Intervention: Acupressure (12-min sessions, three times per week for four weeks on acupoints HT7, PC6, SP6)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 0
Study: 35045327

Group type: EXPERIMENTAL
Intervention: Ertugliflozin (5 mg once daily orally administered)
Number of subjects: 402

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 402
Study: 34137538

Group type: EXPERIMENTAL
Intervention: Single dose of Carbimazole (OD-CMZ)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Divided dose of Carbimazole (DD-CMZ)
Number of subjects: 69
Study: 32450080

Group type: EXPERIMENTAL
Intervention: Single-visit IUD insertion
Number of subjects: 396

Group type: EXPERIMENTAL
Intervention: Parity (associated with willingness to schedule a single-visit insertion)
Number of subjects: 396
Study: 35094230

Group type: EXPERIMENTAL
Intervention: Building the micro‐stellated icosahedrons
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study: 32417946

Group type: EXPERIMENTAL
Intervention: Synbiotic formula of Lactobacillus plantarum PBS067, Lactobacillus acidophilus PBS066 and Lactobacillus reuteri PBS072 with active prebiotics
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 35594632

Group type: EXPERIMENTAL
Intervention: Maternal high-protein diet
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 2
Study: 33657109

Group type: EXPERIMENTAL
Intervention: Malaysian preschoolers' VMI scores
Number of subjects: 435

Group type: COMPARATOR
Intervention: Low-income families
Number of subjects: 435

Group type: COMPARATOR
Intervention: Public preschools
Number of subjects: 435

Group type: COMPARATOR
Intervention: Starting preschool at age six
Number of subjects: 435

Group type: COMPARATOR
Intervention: Low maternal education level
Number of subjects: 435
Study: 34353031

Group type: EXPERIMENTAL
Intervention: LHP's RRPF program (exercise group)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Usual medical care (control group)
Number of subjects: 82
Study: 32167382

Group type: EXPERIMENTAL
Intervention: YpsoPump® Orbit®micro (steel needle)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: YpsoPump® Orbit®soft (soft cannula)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 40
Study: 35144650

Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy (NPWT)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 165
Study: 33812168

Group type: EXPERIMENTAL
Intervention: EPA (4 g daily)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: EPA (in ApoE-/- mice)
Number of subjects: 40
Study: 32076558

Group type: EXPERIMENTAL
Intervention: Simple stenting
Number of subjects: 450

Group type: COMPARATOR
Intervention: Complex stenting
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Newer generation drug-eluting stents (simple stenting)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Newer generation drug-eluting stents (complex stenting)
Number of subjects: 450
Study: 35604803

Group type: EXPERIMENTAL
Intervention: Educational intervention (activating and interactive training sessions for nursing staff and consulting physicians)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 227
Study: 36226089

Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT) combined with conventional treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treatment (Control)
Number of subjects: 0
Study: 33436470

Group type: EXPERIMENTAL
Intervention: Add-on astragalus for 48 weeks
Number of subjects: 118

Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 118
Study: 33718001

Group type: EXPERIMENTAL
Intervention: Internet- and App-based stress intervention (IG)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Internet-based psychoeducational program (CG)
Number of subjects: 200
Study: 33218350

Group type: EXPERIMENTAL
Intervention: Letrozole plus human menopausal gonadotropin (HMG) for endometrial preparation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine artificial hormonal endometrial preparation
Number of subjects: 120
Study: 33080594

Group type: EXPERIMENTAL
Intervention: Very Integrated Program (VIP) - 6-week intensive integrated lifestyle intervention
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Very Integrated Program (VIP) - 12-month follow-up
Number of subjects: 128
Study: 32801017

Group type: EXPERIMENTAL
Intervention: Oral THC:CBD cannabis extract (2.5 mg THC and 2.5 mg CBD, 1-4 self-titrated capsules, three times daily from days -1 to 5)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Oral THC:CBD cannabis extract
Number of subjects: 81
Study: 34288040

Group type: EXPERIMENTAL
Intervention: Intimate partner violence intervention education component
Number of subjects: 178

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 178
Study: 33161293

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training intervention consisting of Xbox 360 Kinect games performed for sixteen 30‐min sessions over 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (details not specified)
Number of subjects: 40
Study: 36122257

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided thoracic erector spinae plane block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ultrasound-guided thoracic paravertebral block
Number of subjects: 60
Study: 34056788

Group type: EXPERIMENTAL
Intervention: Progressive tendon-loading exercises (PTLE)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Eccentric exercise therapy (EET)
Number of subjects: 76
Study: 32805185

Group type: EXPERIMENTAL
Intervention: Luseogliflozin 2.5 mg once daily
Number of subjects: 173

Group type: COMPARATOR
Intervention: Voglibose 0.2 mg 3 times daily
Number of subjects: 173
Study: 35380988

Group type: EXPERIMENTAL
Intervention: Yoga program
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Aerobic and strength training (A+ST)
Number of subjects: 10
Study: 33988886

Group type: EXPERIMENTAL
Intervention: Informed consent procedure
Number of subjects: 146
Study: 34500113

Group type: EXPERIMENTAL
Intervention: Concurrent treatment (SBRT with immunotherapy)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Sequential treatment (SBRT followed by immunotherapy)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Overall response
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Progression-free survival
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 37
Study: 32563642

Group type: EXPERIMENTAL
Intervention: Left Atrial Late Gadolinium Enhancement (LA LGE)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Addition of LA LGE to a multivariable risk prediction model
Number of subjects: 68
Study: 32329037

Group type: EXPERIMENTAL
Intervention: Statin administration (statin + group, 143 patients)
Number of subjects: 344

Group type: COMPARATOR
Intervention: No statin administration (statin - group, 201 patients)
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Statin administration (statin + group)
Number of subjects: 344

Group type: COMPARATOR
Intervention: No statin administration (statin - group)
Number of subjects: 344

Group type: EXPERIMENTAL
Intervention: Both statin (+) and statin (-) groups
Number of subjects: 344
Study: 33611330

Group type: EXPERIMENTAL
Intervention: 1.0% Sodium Carboxymethylcellulose (SCMC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.4% Sodium Hyaluronate (SH)
Number of subjects: 60
Study: 32034447

Group type: EXPERIMENTAL
Intervention: 7-mg nicotine patch (NP)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo patch (PP)
Number of subjects: 127
Study: 33861390

Group type: EXPERIMENTAL
Intervention: Plantago psyllium (10g/day for 7 weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 34786629

Group type: EXPERIMENTAL
Intervention: Early intervention for adolescent depression
Number of subjects: 12
Study: 34454767

Group type: EXPERIMENTAL
Intervention: 2-scale combination (0,1/2,3 or 0/1,2)
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: 2-scale inter-rater agreement
Number of subjects: 524
Study: 32357088

Group type: EXPERIMENTAL
Intervention: Breastfeeding for 2 months
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Mothers providing mostly or only breast milk at 2 months
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Intended breastfeeding duration
Number of subjects: 349
Study: 34256752

Group type: EXPERIMENTAL
Intervention: Combined learning (animations and games)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Routine school education
Number of subjects: 82
Study: 34773608

Group type: EXPERIMENTAL
Intervention: Inhaled Technosphere Insulin (TI) at doses of 10, 30, and 120 U
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subcutaneous insulin lispro (LIS) at doses of 8, 30, and 90 U
Number of subjects: 0
Study: 33966520

Group type: EXPERIMENTAL
Intervention: Laser acupuncture and telerehabilitation sessions (aerobic exercise and virtual reality training)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Telerehabilitation sessions (aerobic exercise and virtual reality training)
Number of subjects: 60
Study: 35063451

Group type: EXPERIMENTAL
Intervention: Telemedical intensivist consultation
Number of subjects: 71

Group type: COMPARATOR
Intervention: Simulated observation by a critical care physician
Number of subjects: 71
Study: 34112384

Group type: EXPERIMENTAL
Intervention: Coronary CT Angiography followed by Invasive Angiography
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 36018628

Group type: EXPERIMENTAL
Intervention: Animated decision aid (n=693, 48.6%)
Number of subjects: 1425

Group type: COMPARATOR
Intervention: Control group (n=732, 51.4%)
Number of subjects: 1425
Study: 32633158

Group type: EXPERIMENTAL
Intervention: Oral vancomycin (OV) at 50 mg/kg/day in 3 divided doses if weight <30kg, and 500 mg 3 times/day if weight ≥30kg.
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Oral vancomycin (OV) treatment.
Number of subjects: 59
Study: 35471812

Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg, amoxicillin 1000 mg, esomeprazole 40 mg, all twice daily for 14 days
Number of subjects: 579

Group type: COMPARATOR
Intervention: Bismuth subcitrate 240 mg twice daily, amoxicillin 1000 mg three times daily, esomeprazole 40 mg twice daily for 14 days
Number of subjects: 579
Study: 33504909

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (DMB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade (MMB)
Number of subjects: 50
Study: 34006849

Group type: EXPERIMENTAL
Intervention: Pharmacogenetic panel-based genotyping
Number of subjects: 77684

Group type: EXPERIMENTAL
Intervention: Combined CYP2C19-CYP2D6 phenotypes
Number of subjects: 77684
Study: 33280888

Group type: EXPERIMENTAL
Intervention: Genetically predicted TMAO
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetically predicted betaine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetically predicted carnitine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetically predicted choline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher risk of AD
Number of subjects: 0
Study: 35007940

Group type: EXPERIMENTAL
Intervention: ICDs exposed to doses of 2, 5, or 10 Gy (6 MV) during radiation exposure
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: PMs exposed to doses of 2, 5, or 10 Gy (6 MV) during radiation exposure
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Follow-up of PMs and ICDs after exposure
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Non-MRI-compatible devices
Number of subjects: 210
Study: 32040047

Group type: EXPERIMENTAL
Intervention: Warmed saline (37.5°C)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nonwarmed saline (22°C‐24°C)
Number of subjects: 80
Study: 35708557

Group type: EXPERIMENTAL
Intervention: Aromatherapy with lavender oil through inhalation and foot massage
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34018042

Group type: EXPERIMENTAL
Intervention: Laparoscopic ventral hernia repair (LVHR)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Open ventral hernia repair (OVHR)
Number of subjects: 85
Study: 32209721

Group type: EXPERIMENTAL
Intervention: Ustekinumab 45 mg or 90 mg
Number of subjects: 747

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 747
Study: 35985899

Group type: EXPERIMENTAL
Intervention: Mobile phone-based life-skills training program (22 weeks duration)
Number of subjects: 1473

Group type: COMPARATOR
Intervention: Assessment-only control condition
Number of subjects: 1473
Study: 33607030

Group type: EXPERIMENTAL
Intervention: Social group intervention (sensitisation and education about MRDT)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Social group plus provider intervention (social group intervention plus provider training in health communication about MRDT)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Social group plus provider intervention (social group intervention plus provider training about MRDT)
Number of subjects: 18
Study: 32216468

Group type: EXPERIMENTAL
Intervention: Lactobacillus fermentum CECT5716 (Lc40) administered to mothers (n=139); 1 capsule/day containing 3×10^9 cfu Lc40
Number of subjects: 291

Group type: COMPARATOR
Intervention: Placebo (maltodextrin) capsule administered to mothers (n=152); 1 capsule/day
Number of subjects: 291
Study: 36397445

Group type: EXPERIMENTAL
Intervention: Random forest model
Number of subjects: 1905

Group type: EXPERIMENTAL
Intervention: Logistic regression model
Number of subjects: 1905

Group type: EXPERIMENTAL
Intervention: Mortality rate
Number of subjects: 1905
Study: 32156479

Group type: EXPERIMENTAL
Intervention: RAAS blockers
Number of subjects: 110

Group type: COMPARATOR
Intervention: Other antihypertensive drugs (Control)
Number of subjects: 110
Study: 36314293

Group type: EXPERIMENTAL
Intervention: Hypocaloric low carbohydrate diet
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Hypocaloric moderate low fat diet
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Mediterranean diet without calorie restriction
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 38
Study: 33450113

Group type: EXPERIMENTAL
Intervention: Early neonatal deaths identified through retrospective chart review
Number of subjects: 2499

Group type: EXPERIMENTAL
Intervention: Causes of early neonatal death
Number of subjects: 2499

Group type: EXPERIMENTAL
Intervention: Avoidable factors identified
Number of subjects: 2499
Study: 32957418

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) treatment, 12 sessions over 4 weeks
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Manual acupuncture (MA) treatment, 12 sessions over 4 weeks
Number of subjects: 144

Group type: COMPARATOR
Intervention: Western medicine group, 20 mg fluoxetine orally per day for 4 weeks
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) treatment
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Manual acupuncture (MA) treatment
Number of subjects: 144

Group type: COMPARATOR
Intervention: Western medicine group
Number of subjects: 144
Study: 36068716

Group type: EXPERIMENTAL
Intervention: Escherichia coli Nissle 1917 (EcN)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 34120941

Group type: EXPERIMENTAL
Intervention: Sports dance exercises
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 32590885

Group type: EXPERIMENTAL
Intervention: Thicker custom-made mouthguard with 2-mm occlusal accommodation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Conventional mouthguard (Type A) with no occlusal accommodation
Number of subjects: 25
Study: 33035738

Group type: EXPERIMENTAL
Intervention: Serum PFAS levels (PFOA, PFOS, PFHxS, PFNA)
Number of subjects: 235
Study: 32330638

Group type: EXPERIMENTAL
Intervention: 200 μg misoprostol
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: 3 mg dinoprostone
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 36042401

Group type: EXPERIMENTAL
Intervention: Lifestyle Intervention (LI) group
Number of subjects: 63

Group type: COMPARATOR
Intervention: Usual Care (UC) group
Number of subjects: 63
Study: 33509703

Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/mL (Gla-300)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-of-care basal insulin (SOC-BI)
Number of subjects: 0
Study: 36315954

Group type: EXPERIMENTAL
Intervention: Thrombectomy alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alteplase + thrombectomy
Number of subjects: 0
Study: 36215911

Group type: EXPERIMENTAL
Intervention: Video observation of methadone take-home dosing
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Full pilot program participants
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Full pilot participants
Number of subjects: 44

Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Clinical outcomes
Number of subjects: 44
Study: 33634446

Group type: EXPERIMENTAL
Intervention: Restarting oral anticoagulation within 14 days
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Restarting oral anticoagulation
Number of subjects: 352
Study: 32778158

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Sham Electroacupuncture (sham EA)
Number of subjects: 94
Study: 34133836

Group type: EXPERIMENTAL
Intervention: 5% topical minoxidil plus SULT1A1 enzyme booster
Number of subjects: 24

Group type: COMPARATOR
Intervention: 5% topical minoxidil plus placebo adjuvant
Number of subjects: 24
Study: 33838094

Group type: EXPERIMENTAL
Intervention: Foot massage with lavender essential oil
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Foot massage with orange essential oil
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (routine care)
Number of subjects: 105
Study: 36150553

Group type: EXPERIMENTAL
Intervention: Environmental impact labels only
Number of subjects: 2730

Group type: EXPERIMENTAL
Intervention: Environmental impact labels with nutrition labels
Number of subjects: 2730

Group type: COMPARATOR
Intervention: Nutrition labels only
Number of subjects: 2730

Group type: COMPARATOR
Intervention: Both environmental and nutrition labels
Number of subjects: 2730

Group type: COMPARATOR
Intervention: No labels (control)
Number of subjects: 2730
Study: 33393617

Group type: EXPERIMENTAL
Intervention: Weighted mode method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MRMix method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random-effect IVW method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MR-Robust method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MR-RAPS method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Various MR methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Down-sampling analysis
Number of subjects: 0